FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908113313> ?p ?o ?g. }

• W2908113313 endingPage "e1002719" @default.
• W2908113313 startingPage "e1002719" @default.
• W2908113313 abstract "Background Conventional HIV testing services have been less comprehensive in reaching men than in reaching women globally, but HIV self-testing (HIVST) appears to be an acceptable alternative. Measurement of linkage to post-test services following HIVST remains the biggest challenge, yet is the biggest driver of cost-effectiveness. We investigated the impact of HIVST alone or with additional interventions on the uptake of testing and linkage to care or prevention among male partners of antenatal care clinic attendees in a novel adaptive trial. Methods and findings An adaptive multi-arm, 2-stage cluster randomised trial was conducted between 8 August 2016 and 30 June 2017, with antenatal care clinic (ANC) days (i.e., clusters of women attending on a single day) as the unit of randomisation. Recruitment was from Ndirande, Bangwe, and Zingwangwa primary health clinics in urban Blantyre, Malawi. Women attending an ANC for the first time for their current pregnancy (regardless of trimester), 18 years and older, with a primary male partner not known to be on ART were enrolled in the trial after giving consent. Randomisation was to either the standard of care (SOC; with a clinic invitation letter to the male partner) or 1 of 5 intervention arms: the first arm provided women with 2 HIVST kits for their partners; the second and third arms provided 2 HIVST kits along with a conditional fixed financial incentive of $3 or $10; the fourth arm provided 2 HIVST kits and a 10% chance of receiving $30 in a lottery; and the fifth arm provided 2 HIVST kits and a phone call reminder for the women’s partners. The primary outcome was the proportion of male partners who were reported to have tested for HIV and linked into care or prevention within 28 days, with referral for antiretroviral therapy (ART) or circumcision accordingly. Women were interviewed at 28 days about partner testing and adverse events. Cluster-level summaries compared each intervention versus SOC using eligible women as the denominator (intention-to-treat). Risk ratios were adjusted for male partner testing history and recruitment clinic. A total of 2,349/3,137 (74.9%) women participated (71 ANC days), with a mean age of 24.8 years (SD: 5.4). The majority (2,201/2,233; 98.6%) of women were married, 254/2,107 (12.3%) were unable to read and write, and 1,505/2,247 (67.0%) were not employed. The mean age for male partners was 29.6 years (SD: 7.5), only 88/2,200 (4.0%) were unemployed, and 966/2,210 (43.7%) had never tested for HIV before. Women in the SOC arm reported that 17.4% (71/408) of their partners tested for HIV, whereas a much higher proportion of partners were reported to have tested for HIV in all intervention arms (87.0%–95.4%, p < 0.001 in all 5 intervention arms). As compared with those who tested in the SOC arm (geometric mean 13.0%), higher proportions of partners met the primary endpoint in the HIVST + $3 (geometric mean 40.9%, adjusted risk ratio [aRR] 3.01 [95% CI 1.63–5.57], p < 0.001), HIVST + $10 (51.7%, aRR 3.72 [95% CI 1.85–7.48], p < 0.001), and phone reminder (22.3%, aRR 1.58 [95% CI 1.07–2.33], p = 0.021) arms. In contrast, there was no significant increase in partners meeting the primary endpoint in the HIVST alone (geometric mean 17.5%, aRR 1.45 [95% CI 0.99–2.13], p = 0.130) or lottery (18.6%, aRR 1.43 [95% CI 0.96–2.13], p = 0.211) arms. The lottery arm was dropped at interim analysis. Overall, 46 male partners were confirmed to be HIV positive, 42 (91.3%) of whom initiated ART within 28 days; 222 tested HIV negative and were not already circumcised, of whom 135 (60.8%) were circumcised as part of the trial. No serious adverse events were reported. Costs per male partner who attended the clinic with a confirmed HIV test result were $23.73 and $28.08 for the HIVST + $3 and HIVST + $10 arms, respectively. Notable limitations of the trial included the relatively small number of clusters randomised to each arm, proxy reporting of the male partner testing outcome, and being unable to evaluate retention in care. Conclusions In this study, the odds of men’s linkage to care or prevention increased substantially using conditional fixed financial incentives plus partner-delivered HIVST; combinations were potentially affordable. Trial registration ISRCTN 18421340." @default.
• W2908113313 created "2019-01-11" @default.
• W2908113313 creator A5003587385 @default.
• W2908113313 creator A5031097700 @default.
• W2908113313 creator A5033232150 @default.
• W2908113313 creator A5047829154 @default.
• W2908113313 creator A5072107193 @default.
• W2908113313 creator A5075399093 @default.
• W2908113313 creator A5080859282 @default.
• W2908113313 creator A5082249530 @default.
• W2908113313 creator A5087136833 @default.
• W2908113313 creator A5090276267 @default.
• W2908113313 creator A5091777537 @default.
• W2908113313 date "2019-01-02" @default.
• W2908113313 modified "2023-10-18" @default.
• W2908113313 title "HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial" @default.
• W2908113313 cites W1811824508 @default.
• W2908113313 cites W1983018462 @default.
• W2908113313 cites W2001396122 @default.
• W2908113313 cites W2012757283 @default.
• W2908113313 cites W2015771929 @default.
• W2908113313 cites W2041073238 @default.
• W2908113313 cites W2060160398 @default.
• W2908113313 cites W2136685221 @default.
• W2908113313 cites W2154844485 @default.
• W2908113313 cites W2155896563 @default.
• W2908113313 cites W2156258495 @default.
• W2908113313 cites W2162730683 @default.
• W2908113313 cites W2166202995 @default.
• W2908113313 cites W2171820889 @default.
• W2908113313 cites W2287489474 @default.
• W2908113313 cites W2293073501 @default.
• W2908113313 cites W2315209851 @default.
• W2908113313 cites W2556949014 @default.
• W2908113313 cites W2612200313 @default.
• W2908113313 cites W2626716901 @default.
• W2908113313 cites W2630041389 @default.
• W2908113313 cites W2738849701 @default.
• W2908113313 cites W2740730727 @default.
• W2908113313 cites W2746659324 @default.
• W2908113313 cites W2768692582 @default.
• W2908113313 cites W2769247552 @default.
• W2908113313 cites W2770120060 @default.
• W2908113313 cites W2787572544 @default.
• W2908113313 doi "https://doi.org/10.1371/journal.pmed.1002719" @default.
• W2908113313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6314606" @default.
• W2908113313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30601823" @default.
• W2908113313 hasPublicationYear "2019" @default.
• W2908113313 type Work @default.
• W2908113313 sameAs 2908113313 @default.
• W2908113313 citedByCount "111" @default.
• W2908113313 countsByYear W29081133132019 @default.
• W2908113313 countsByYear W29081133132020 @default.
• W2908113313 countsByYear W29081133132021 @default.
• W2908113313 countsByYear W29081133132022 @default.
• W2908113313 countsByYear W29081133132023 @default.
• W2908113313 crossrefType "journal-article" @default.
• W2908113313 hasAuthorship W2908113313A5003587385 @default.
• W2908113313 hasAuthorship W2908113313A5031097700 @default.
• W2908113313 hasAuthorship W2908113313A5033232150 @default.
• W2908113313 hasAuthorship W2908113313A5047829154 @default.
• W2908113313 hasAuthorship W2908113313A5072107193 @default.
• W2908113313 hasAuthorship W2908113313A5075399093 @default.
• W2908113313 hasAuthorship W2908113313A5080859282 @default.
• W2908113313 hasAuthorship W2908113313A5082249530 @default.
• W2908113313 hasAuthorship W2908113313A5087136833 @default.
• W2908113313 hasAuthorship W2908113313A5090276267 @default.
• W2908113313 hasAuthorship W2908113313A5091777537 @default.
• W2908113313 hasBestOaLocation W29081133131 @default.
• W2908113313 hasConcept C159110408 @default.
• W2908113313 hasConcept C162324750 @default.
• W2908113313 hasConcept C175444787 @default.
• W2908113313 hasConcept C176400912 @default.
• W2908113313 hasConcept C27415008 @default.
• W2908113313 hasConcept C2780665704 @default.
• W2908113313 hasConcept C2908647359 @default.
• W2908113313 hasConcept C29122968 @default.
• W2908113313 hasConcept C512399662 @default.
• W2908113313 hasConcept C71924100 @default.
• W2908113313 hasConcept C99454951 @default.
• W2908113313 hasConceptScore W2908113313C159110408 @default.
• W2908113313 hasConceptScore W2908113313C162324750 @default.
• W2908113313 hasConceptScore W2908113313C175444787 @default.
• W2908113313 hasConceptScore W2908113313C176400912 @default.
• W2908113313 hasConceptScore W2908113313C27415008 @default.
• W2908113313 hasConceptScore W2908113313C2780665704 @default.
• W2908113313 hasConceptScore W2908113313C2908647359 @default.
• W2908113313 hasConceptScore W2908113313C29122968 @default.
• W2908113313 hasConceptScore W2908113313C512399662 @default.
• W2908113313 hasConceptScore W2908113313C71924100 @default.
• W2908113313 hasConceptScore W2908113313C99454951 @default.
• W2908113313 hasFunder F4320307874 @default.
• W2908113313 hasIssue "1" @default.
• W2908113313 hasLocation W29081133131 @default.
• W2908113313 hasLocation W29081133132 @default.
• W2908113313 hasLocation W29081133133 @default.
• W2908113313 hasLocation W29081133134 @default.
• W2908113313 hasLocation W29081133135 @default.

• next